Matches in Wikidata for { <http://www.wikidata.org/entity/Q61651075> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q61651075 description "article scientifique publié en 1997" @default.
- Q61651075 description "artículu científicu espublizáu en payares de 1997" @default.
- Q61651075 description "im November 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61651075 description "scientific article published on 01 November 1997" @default.
- Q61651075 description "wetenschappelijk artikel" @default.
- Q61651075 description "наукова стаття, опублікована в листопаді 1997" @default.
- Q61651075 description "գիտական հոդված հրատարակված 1997 թվականի նոյեմբերի 1-ին" @default.
- Q61651075 name "Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes" @default.
- Q61651075 name "Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes" @default.
- Q61651075 type Item @default.
- Q61651075 label "Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes" @default.
- Q61651075 label "Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes" @default.
- Q61651075 prefLabel "Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes" @default.
- Q61651075 prefLabel "Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes" @default.
- Q61651075 P1433 Q61651075-1DB1E95B-9942-415E-8717-18EDCA2D02D3 @default.
- Q61651075 P1476 Q61651075-4C472E00-FCB6-44C3-8E30-DF9F7912C148 @default.
- Q61651075 P2093 Q61651075-1D84C186-1AB9-4B4D-93CB-F9D3AA2572AF @default.
- Q61651075 P2093 Q61651075-2348BC03-52E5-44DF-8B49-961ECCDFBA88 @default.
- Q61651075 P2093 Q61651075-43BFE2E7-6289-44F2-82EF-D9EF85E713B3 @default.
- Q61651075 P2093 Q61651075-49D96670-3848-4330-8086-3828F33D5DEE @default.
- Q61651075 P2093 Q61651075-67B746C2-A38B-4C9C-8338-030CCE9A67BF @default.
- Q61651075 P2093 Q61651075-77EBF009-B7D9-43A2-9820-A0F5BE72189C @default.
- Q61651075 P304 Q61651075-9CDF5232-7A2E-4D4A-900E-DBC88D668D39 @default.
- Q61651075 P31 Q61651075-40D9A76D-6C81-4B7C-B97B-5141A0E4AD7C @default.
- Q61651075 P407 Q61651075-6294D09D-33A4-4224-A157-7AE30F8DE363 @default.
- Q61651075 P433 Q61651075-1308D29E-D9B4-483B-9D42-101BE835C3DB @default.
- Q61651075 P478 Q61651075-56C41F87-65F4-4626-B8B4-9A0065145758 @default.
- Q61651075 P50 Q61651075-7B6A3263-7C31-484B-9B7D-E93663A2E6C7 @default.
- Q61651075 P577 Q61651075-6A392744-E4A3-4698-8A94-7E98712A853D @default.
- Q61651075 P698 Q61651075-F6397F7F-1AF6-4A40-86E4-9627558B6F0C @default.
- Q61651075 P921 Q61651075-69E2F6C7-4A45-4120-B8CC-B09B71F8721B @default.
- Q61651075 P698 9499664 @default.
- Q61651075 P1433 Q5638209 @default.
- Q61651075 P1476 "Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high-risk myelodysplastic syndromes" @default.
- Q61651075 P2093 "Ascari E" @default.
- Q61651075 P2093 "Giusto M" @default.
- Q61651075 P2093 "Invernizzi R" @default.
- Q61651075 P2093 "Pecci A" @default.
- Q61651075 P2093 "Pelizzari AM" @default.
- Q61651075 P2093 "Rossi G" @default.
- Q61651075 P304 "660-663" @default.
- Q61651075 P31 Q13442814 @default.
- Q61651075 P407 Q1860 @default.
- Q61651075 P433 "6" @default.
- Q61651075 P478 "82" @default.
- Q61651075 P50 Q37839539 @default.
- Q61651075 P577 "1997-11-01T00:00:00Z" @default.
- Q61651075 P698 "9499664" @default.
- Q61651075 P921 Q180983 @default.